NICE Briefs: Oncotype Dx; Implantable Heart Failure Monitors; Endobronchial Valves; RF Ablation
This article was originally published in The Gray Sheet
Executive Summary
The U.K.’s National Institute for Health and Care Excellence (NICE) gives a thumbs-up to Genomic Health’s Oncotype DX test for breast cancer, and offers cautious support for implantable pulmonary artery pressure monitors in heart failure patients and endobronchial valves in emphysema patients. More NICE news.